Matches in SemOpenAlex for { <https://semopenalex.org/work/W336984609> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W336984609 endingPage "15" @default.
- W336984609 startingPage "9" @default.
- W336984609 abstract "Electron paramagnetic resonance (EPR) spectroscopy was used to examine insulins interactions with free radicals. Human recombinant DNA insulins of three groups were studied: short-acting insulin (Insuman Rapid); intermediate-acting insulins (Humulin N, Insuman Basal), and pre-mixed insulins (Humulin M3, Gensulin M50, Gensulin M40, Gensulin M30). The aim of an X-band (9.3GHz) study was comparative analysis of antioxidative properties of the three groups of human insulins. DPPH was used as a stable free radical model. Amplitudes of EPR lines of DPPH as the paramagnetic free radical reference, and DPPH interacting with the individual tested insulins were compared. For all the examined insulins kinetics of their interactions with free radicals up to 60 min were obtained. The strongest interactions with free radicals were observed for the short-acting insulin - Insuman Rapid. The lowest interactions with free radicals were characteristic for intermediate-acting insulin - Insuman Basal. The pre-mixed insulins i.e. Humulin M3 and Gensulin M50 revealed the fastest interactions with free radicals. The short acting, intermediate acting and premixed insulins have been found to be effective agents in reducing free radical formation in vitro and should be further considered as potential useful tools in attenuation of oxidative stress in diabetic patients." @default.
- W336984609 created "2016-06-24" @default.
- W336984609 creator A5022450170 @default.
- W336984609 creator A5034896892 @default.
- W336984609 creator A5061331070 @default.
- W336984609 creator A5074713011 @default.
- W336984609 creator A5076989282 @default.
- W336984609 creator A5090285280 @default.
- W336984609 date "2015-07-01" @default.
- W336984609 modified "2023-09-24" @default.
- W336984609 title "Interactions of short-acting, intermediate-acting and pre-mixed human insulins with free radicals—Comparative EPR examination" @default.
- W336984609 cites W1504142642 @default.
- W336984609 cites W1508167383 @default.
- W336984609 cites W1965779389 @default.
- W336984609 cites W1974616262 @default.
- W336984609 cites W1990045305 @default.
- W336984609 cites W2010826728 @default.
- W336984609 cites W2014856755 @default.
- W336984609 cites W2029485903 @default.
- W336984609 cites W2054327773 @default.
- W336984609 cites W2076219300 @default.
- W336984609 cites W2076236703 @default.
- W336984609 cites W2089657910 @default.
- W336984609 cites W2105892231 @default.
- W336984609 cites W2108209937 @default.
- W336984609 cites W2118542451 @default.
- W336984609 cites W2123429985 @default.
- W336984609 cites W2131212756 @default.
- W336984609 cites W2134467550 @default.
- W336984609 cites W2141083523 @default.
- W336984609 cites W2145825933 @default.
- W336984609 cites W2151269150 @default.
- W336984609 cites W2163286839 @default.
- W336984609 cites W2181982717 @default.
- W336984609 cites W2185878010 @default.
- W336984609 cites W36303043 @default.
- W336984609 cites W48130222 @default.
- W336984609 cites W577874856 @default.
- W336984609 doi "https://doi.org/10.1016/j.ijpharm.2015.05.022" @default.
- W336984609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25975232" @default.
- W336984609 hasPublicationYear "2015" @default.
- W336984609 type Work @default.
- W336984609 sameAs 336984609 @default.
- W336984609 citedByCount "0" @default.
- W336984609 crossrefType "journal-article" @default.
- W336984609 hasAuthorship W336984609A5022450170 @default.
- W336984609 hasAuthorship W336984609A5034896892 @default.
- W336984609 hasAuthorship W336984609A5061331070 @default.
- W336984609 hasAuthorship W336984609A5074713011 @default.
- W336984609 hasAuthorship W336984609A5076989282 @default.
- W336984609 hasAuthorship W336984609A5090285280 @default.
- W336984609 hasConcept C121332964 @default.
- W336984609 hasConcept C139066938 @default.
- W336984609 hasConcept C148898269 @default.
- W336984609 hasConcept C185592680 @default.
- W336984609 hasConcept C187961010 @default.
- W336984609 hasConcept C2778004101 @default.
- W336984609 hasConcept C2781401929 @default.
- W336984609 hasConcept C46141821 @default.
- W336984609 hasConcept C55493867 @default.
- W336984609 hasConcept C62520636 @default.
- W336984609 hasConcept C75473681 @default.
- W336984609 hasConceptScore W336984609C121332964 @default.
- W336984609 hasConceptScore W336984609C139066938 @default.
- W336984609 hasConceptScore W336984609C148898269 @default.
- W336984609 hasConceptScore W336984609C185592680 @default.
- W336984609 hasConceptScore W336984609C187961010 @default.
- W336984609 hasConceptScore W336984609C2778004101 @default.
- W336984609 hasConceptScore W336984609C2781401929 @default.
- W336984609 hasConceptScore W336984609C46141821 @default.
- W336984609 hasConceptScore W336984609C55493867 @default.
- W336984609 hasConceptScore W336984609C62520636 @default.
- W336984609 hasConceptScore W336984609C75473681 @default.
- W336984609 hasIssue "1-2" @default.
- W336984609 hasLocation W3369846091 @default.
- W336984609 hasLocation W3369846092 @default.
- W336984609 hasOpenAccess W336984609 @default.
- W336984609 hasPrimaryLocation W3369846091 @default.
- W336984609 hasRelatedWork W1980154275 @default.
- W336984609 hasRelatedWork W1986445704 @default.
- W336984609 hasRelatedWork W2042807776 @default.
- W336984609 hasRelatedWork W2065939529 @default.
- W336984609 hasRelatedWork W2163859853 @default.
- W336984609 hasRelatedWork W2365267565 @default.
- W336984609 hasRelatedWork W2381986359 @default.
- W336984609 hasRelatedWork W2952655335 @default.
- W336984609 hasRelatedWork W3003680778 @default.
- W336984609 hasRelatedWork W3011335974 @default.
- W336984609 hasVolume "490" @default.
- W336984609 isParatext "false" @default.
- W336984609 isRetracted "false" @default.
- W336984609 magId "336984609" @default.
- W336984609 workType "article" @default.